YC W26
Origin
AI and Data for Cancer Therapeutics
About
Creating the largest patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies. These datasets are unique as they screen the effects of various drugs and genetic medicines under the control of our DNA switches.
Founders
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Origin.
See family office activityIndustry & Focus
HealthcareDrug Discovery and Delivery